• DOI:10.1007/s40265-019-01069-1
Corpus ID: 67790108

Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety

@article{Lattanzi2019ErenumabFP,
  title={Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety},
  author={S. Lattanzi and Francesco Brigo and E. Trinka and F. Vernieri and Tommaso Corradetti and M. Dobran and M. Silvestrini},
  journal={Drugs},
  year={2019},
  volume={79},
  pages={417-431}
}

S. Lattanzi, Francesco Brigo, +4 authors M. Silvestrini

Published 2019

Medicine

Drugs

BackgroundNovel therapeutic options with improved efficacy and safety profiles are needed for the prophylaxis of migraine. In recent years, the inhibition of calcitonin gene-related peptide (CGRP) signaling has attracted growing interest in the pharmacological research on migraine. Erenumab is the first fully human monoclonal antibody directed against the CGRP receptor to be approved for use in migraineurs.ObjectiveTo evaluate the efficacy and safety of erenumab as preventive treatment in… CONTINUE READING

View on Springer

eduardojanuzzi.com.br

Save to Library

Create Alert

Cite

Launch Research Feed